Pelthos Therapeutics Receivables

Pelthos Therapeutics (PTHS) currently reports a receivables of $14M as of June 2026. That compares with $40K in the prior-year period — up 35746.5% year over year. Use the charts on this page to explore Pelthos Therapeutics's receivables history and peer comparisons.

Pelthos Therapeutics's receivables increased from $40K to $14M — a 35746.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pelthos Therapeutics reported $14M in receivables as of June 2026. That compares with $40K in the prior-year period — up 35746.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pelthos Therapeutics, and consider following PTHS for alerts when major investors trade the stock.